Hillsdale Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-130	Closed	-$6.64K	–	598
2024 Q3	$6.64K	Hold	130	–	–	﹤0.01%	552
2024 Q2	$5.82K	Hold	130	–	–	﹤0.01%	546
2024 Q1	$6.09K	Buy	+130	New	+$6.09K	﹤0.01%	547